A COVID-19 vaccine candidate being produced by biotech company Moderna has shown to be 94.5% effective in Phase 3 clinical trials, the company said Monday.
Second COVID vaccine shows promise
Credit: FOX 4 Now Florida
Duration: 00:30s
0 shares
1 views
You might like
Related news coverage
Advertisement
More coverage
Moderna seeks U.S., EU vaccine authorization
Reuters - Politics
[NFA] Moderna will apply for U.S. and European emergency-use authorization for its COVID-19 vaccine on Monday after full results..
Moderna to Submit COVID-19 Vaccine for FDA Regulatory Approval
Wibbitz Top Stories
Breaking News: Moderna To Apply For Emergency Use
WAAY ABC Huntsville, AL
More Than 138,000 New COVID Cases Confirmed Across U.S.
CBS 2 New York
